Published in Arch Ophthalmol on February 01, 2008
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2011) 2.66
Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol (2012) 2.23
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Dry eye as a mucosal autoimmune disease. Int Rev Immunol (2013) 1.85
The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci (2011) 1.49
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res (2012) 1.32
Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci (2009) 1.21
Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol (2011) 1.18
Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol (2012) 1.18
Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol (2010) 1.18
Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am J Pathol (2009) 1.17
Very late antigen-1 mediates corneal lymphangiogenesis. Invest Ophthalmol Vis Sci (2011) 1.11
Age-related changes in the meibomian gland. Exp Eye Res (2009) 1.10
Significance of lipid mediators in corneal injury and repair. J Lipid Res (2009) 1.08
Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids (2010) 1.07
Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol (2011) 1.04
Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol (2011) 1.01
Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol (2011) 1.00
Dry eye syndrome. J Ophthalmic Vis Res (2011) 0.99
Dry eye disease: A review of diagnostic approaches and treatments. Saudi J Ophthalmol (2014) 0.98
The core mechanism of dry eye disease is inflammation. Eye Contact Lens (2014) 0.98
Resolution, the grail for healthy ocular inflammation. Exp Eye Res (2010) 0.97
Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol (2009) 0.96
Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol (2010) 0.93
The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci (2013) 0.93
Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci (2013) 0.92
Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care (2011) 0.90
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea (2011) 0.90
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol (2014) 0.89
Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Invest Ophthalmol Vis Sci (2009) 0.88
PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.82
CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. Invest Ophthalmol Vis Sci (2014) 0.82
Increased lymphangiogenesis and hemangiogenesis in infant cornea. Lymphat Res Biol (2011) 0.82
Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit (2014) 0.81
Neurotransmitter influence on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci (2011) 0.80
Essential fatty acids in the treatment of dry eye syndrome: A myth or reality? Saudi J Ophthalmol (2014) 0.80
No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
14-3-3σ controls corneal epithelium homeostasis and wound healing. Invest Ophthalmol Vis Sci (2011) 0.79
Effect of human milk as a treatment for dry eye syndrome in a mouse model. Mol Vis (2016) 0.77
Treating ocular surface disease: new agents in development. Clin Ophthalmol (2011) 0.77
Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye. Oxid Med Cell Longev (2016) 0.77
Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). BMC Ophthalmol (2015) 0.77
Use of linseed oil to treat experimentally induced keratoconjunctivitis sicca in rabbits. J Ophthalmic Inflamm Infect (2013) 0.77
Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model. Mol Vis (2015) 0.76
Resolvins and aliamides: lipid autacoids in ophthalmology - what promise do they hold? Drug Des Devel Ther (2016) 0.76
Omega-3 fatty acid supplementation can improve both symptoms and signs of dry eye disease. Clin Interv Aging (2017) 0.75
[In Process Citation] J Clin Aesthet Dermatol (2008) 0.75
Optimizing evaluation of Lissamine Green parameters for ocular surface staining. Eye (Lond) (2011) 0.75
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid. J Inflamm (Lond) (2015) 0.75
Effects of silk fibroin in murine dry eye. Sci Rep (2017) 0.75
Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping. J Ocul Pharmacol Ther (2016) 0.75
Sjögren syndrome: what and where are we looking for? Curr Opin Ophthalmol (2015) 0.75
Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev (2016) 0.75
The role of lipids in corneal diseases and dystrophies: a systematic review. Clin Transl Med (2017) 0.75
Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. Cornea (2017) 0.75
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest (2004) 5.59
Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med (2004) 2.64
Accumulated lead exposure and risk of age-related cataract in men. JAMA (2004) 2.29
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27
Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract. Nat Genet (2002) 2.21
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol (2003) 2.08
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes (2004) 2.03
Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea (2003) 2.00
Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci (2002) 1.97
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A (2006) 1.81
Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci (2002) 1.80
Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med (2002) 1.79
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr (2005) 1.57
Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet (2012) 1.57
The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci (2005) 1.55
Corneal antigen-presenting cells. Chem Immunol Allergy (2007) 1.53
Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci (2002) 1.48
The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci (2011) 1.46
Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology (2011) 1.43
Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol (2003) 1.43
Epidemiology of dry eye syndrome. Adv Exp Med Biol (2002) 1.43
Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol (2004) 1.40
Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci (2004) 1.40
Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol (2013) 1.37
Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol (2006) 1.33
Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol (2002) 1.30
Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol (2003) 1.28
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27
Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol (2008) 1.25
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care (2008) 1.25
Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol (2006) 1.24
Dry eye syndromes. Chem Immunol Allergy (2007) 1.24
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol (2009) 1.23
Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea (2002) 1.23
Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci (2005) 1.22
Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci (2009) 1.21
Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need. Ocul Surf (2012) 1.19
The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol (2007) 1.17
Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol (2007) 1.17
Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol (2007) 1.16
The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis (2007) 1.16
Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea (2007) 1.14
A novel mutation in GJA3 (connexin46) for autosomal dominant congenital nuclear pulverulent cataract. Mol Vis (2003) 1.13
Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci (2004) 1.13
Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea (2003) 1.12
A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol (2011) 1.11
9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation (2012) 1.11
Very late antigen-1 mediates corneal lymphangiogenesis. Invest Ophthalmol Vis Sci (2011) 1.11
Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol (2005) 1.09
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics (2011) 1.08
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res (2004) 1.08
A novel pro-lymphangiogenic function for Th17/IL-17. Blood (2011) 1.08
Dry Eye Disease: Impact on Quality of Life and Vision. Curr Ophthalmol Rep (2013) 1.07
CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Invest Ophthalmol Vis Sci (2005) 1.06
Preoperative characteristics and a potential mechanism of chronic dry eye after LASIK. Invest Ophthalmol Vis Sci (2008) 1.05
Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea (2005) 1.05
The gamma S-crystallin gene is mutated in autosomal recessive cataract in mouse. Genomics (2002) 1.03
Predictors of prolonged length of stay after major elective head and neck surgery. Laryngoscope (2007) 1.02
Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res (2009) 1.02
Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol (2011) 1.00
Novel characterization of lymphatic valve formation during corneal inflammation. PLoS One (2011) 1.00
Effect of the ocular microenvironment in regulating corneal dendritic cell maturation. Arch Ophthalmol (2007) 0.99
Mutation screening of HSF4 in 150 age-related cataract patients. Mol Vis (2008) 0.99
Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res (2003) 0.98
Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. JAMA Ophthalmol (2013) 0.97
Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia. Am J Ophthalmol (2005) 0.97
Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) study. Am J Ophthalmol (2003) 0.95
Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res (2009) 0.95
Construction of human corneal endothelial cDNA library and identification of novel active genes. Invest Ophthalmol Vis Sci (2002) 0.94
Fruit and vegetable intake and the risk of cataract in women. Am J Clin Nutr (2005) 0.93
Corneal graft rejection. Int Ophthalmol Clin (2009) 0.92
Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res (2004) 0.92
Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol (2008) 0.91
C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. JAMA Ophthalmol (2013) 0.91
Kinetics and function of mesenchymal stem cells in corneal injury. Invest Ophthalmol Vis Sci (2012) 0.91
The global sex disparity in blindness and visual impairment. Optom Vis Sci (2006) 0.91
Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage. Blood (2013) 0.91
Microdebrider tonsillotomy vs electrosurgical tonsillectomy: a randomized, double-blind, paired control study of postoperative pain. Arch Otolaryngol Head Neck Surg (2006) 0.91
Exposure to a dry environment induces strain-specific responses in mice. Exp Eye Res (2007) 0.90
Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol (2008) 0.90
Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration. Angiogenesis (2012) 0.90
Are women with Sjögren's syndrome androgen-deficient? J Rheumatol (2003) 0.89
The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci (2013) 0.89
Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther (2009) 0.88